30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Food & Drug Retailing

Guardian Pharmacy Services Inc (GRDN)

Track

The most recent insider trading activity occurred on March 20, 2026, with significant sell-offs by multiple insiders, including John Ackerman, David K. Morris, Fred Burke, and entities like Bindley Capital Partners I, LLC. These transactions involved a substantial number of shares and high values, indicating a notable divestment. The last buy transaction was on December 3, 2025.
Stock chart
Ticker: GRDN Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Cardinal Equity Fund, L.P.
Member of 10% owner group
1 sale — total 8,184,296 USD
Sale 20 Mar 2026
Value US$4,515,167.85 | Price 388.77 | Shares 59,398
Sale 20 Mar 2026
Value US$27,002.30 | Price 188.94 | Shares 72,056
Sale 20 Mar 2026
Value US$5,576,006.04 | Price 29.68 | Shares 187,855
Sale 20 Mar 2026
Value US$19,929,780.34 | Price 29.68 | Shares 671,432
Sale 20 Mar 2026
Value US$10,290,091.64 | Price 29.68 | Shares 346,672
Sale 20 Mar 2026
Value US$105,986,620.05 | Price 29.68 | Shares 3,570,677
Sale 20 Mar 2026
Value US$8,184,296.36 | Price 29.68 | Shares 275,728
Sale 20 Mar 2026
Value US$24,566,305.57 | Price 29.68 | Shares 827,636
Sale 20 Mar 2026
Value US$105,986,620.05 | Price 29.68 | Shares 3,570,677
Sale 20 Mar 2026
Value US$105,986,620.05 | Price 29.68 | Shares 3,570,677
Buy 3 Dec 2025
Value US$99,785.70 | Price 29.61 | Shares 3,370
Sale 28 May 2025
Value US$3,044,119.68 | Price 20.16 | Shares 150,998
Sale 28 May 2025
Value US$1,014,148.80 | Price 20.16 | Shares 50,305
Sale 28 May 2025
Value US$1,381,907.52 | Price 20.16 | Shares 68,547
Sale 28 May 2025
Value US$1,310,218.56 | Price 20.16 | Shares 64,991
Sale 28 May 2025
Value US$13,133,312.64 | Price 20.16 | Shares 651,454
Sale 28 May 2025
Value US$2,796,292.80 | Price 20.16 | Shares 138,705
Sale 28 May 2025
Value US$13,133,312.64 | Price 20.16 | Shares 651,454
Sale 28 May 2025
Value US$1,014,148.80 | Price 20.16 | Shares 50,305
Sale 28 May 2025
Value US$3,044,119.68 | Price 20.16 | Shares 150,998
Sale 28 May 2025
Value US$13,133,312.64 | Price 20.16 | Shares 651,454
Sale 27 May 2025
Value US$16,396,490.88 | Price 20.16 | Shares 813,318
Sale 27 May 2025
Value US$5,462,513.28 | Price 20.16 | Shares 270,958
Sale 27 May 2025
Value US$7,443,313.92 | Price 20.16 | Shares 369,212
Sale 27 May 2025
Value US$7,057,169.28 | Price 20.16 | Shares 350,058
Sale 27 May 2025
Value US$70,739,524.80 | Price 20.16 | Shares 3,508,905
Sale 27 May 2025
Value US$15,061,576.32 | Price 20.16 | Shares 747,102
Sale 27 May 2025
Value US$70,739,524.80 | Price 20.16 | Shares 3,508,905
Sale 27 May 2025
Value US$5,462,513.28 | Price 20.16 | Shares 270,958
Sale 27 May 2025
Value US$16,396,490.88 | Price 20.16 | Shares 813,318
Sale 27 May 2025
Value US$70,739,524.80 | Price 20.16 | Shares 3,508,905
Buy 19 Nov 2024
Value US$148,540.00 | Price 21.22 | Shares 7,000
Buy 27 Sep 2024
Value US$499,996.00 | Price 14.00 | Shares 35,714
Buy 27 Sep 2024
Value US$99,988.00 | Price 14.00 | Shares 7,142
Buy 27 Sep 2024
Value US$49,994.00 | Price 14.00 | Shares 3,571
Buy 27 Sep 2024
Value US$49,994.00 | Price 14.00 | Shares 3,571
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-24 2026-03-20 S Sale
0.7
Cardinal Equity Fund, L.P.

Member of 10% owner group
59,398 -49.3%
388.77
US$4,515,168 		59,398 -49.3% 388.77 US$4,515,168
2026-03-24 2026-03-20 S Sale
0.7
Pharmacy Investors, LLC

Member of 10% owner group
72,056 +10.3%
188.94
US$27,002 		72,056 +10.3% 188.94 US$27,002
2026-03-24 2026-03-20 S Sale
0.7
Morris David K

See Remarks

Executive Director
38,101 +19.7%
424.42
US$3,257,465 		38,101 +19.7% 424.42 US$3,257,465
2026-03-24 2026-03-20 S Sale
0.7
Burke Fred

See Remarks

Executive Director
671,432 -44.4%
29.68
US$19,929,780 		671,432 -44.4% 29.68 US$19,929,780
2026-03-24 2026-03-20 S Sale
0.7
Forbes Kendall

See Remarks

Officer
346,672 -43.3%
29.68
US$10,290,092 		346,672 -43.3% 29.68 US$10,290,092
2026-03-24 2026-03-20 S Sale
0.7
Bindley Capital Partners I, LLC
Large shareholder
3,570,677 -44.4%
29.68
US$105,986,620 		3,570,677 -44.4% 29.68 US$105,986,620
2026-03-24 2026-03-20 S Sale
0.7
Ackerman John
Non-Executive Director
275,728 -44.4%
29.68
US$8,184,296 		275,728 -44.4% 29.68 US$8,184,296
2026-03-24 2026-03-20 S Sale
0.7
Ackerman John
Non-Executive Director
827,636 -44.4%
29.68
US$24,566,306 		827,636 -44.4% 29.68 US$24,566,306
2026-03-24 2026-03-20 S Sale
0.7
BINDLEY WILLIAM E
Non-Executive Director Large shareholder
3,570,677 -44.4%
29.68
US$105,986,620 		3,570,677 -44.4% 29.68 US$105,986,620
2026-03-24 2026-03-20 S Sale
0.7
Salentine Thomas J Jr
Non-Executive Director Large shareholder
3,570,677 -44.4%
29.68
US$105,986,620 		3,570,677 -44.4% 29.68 US$105,986,620
2025-12-05 2025-12-03 B Purchase
2.8
COSLER STEVEN D
Non-Executive Director
3,370 +15.6%
29.61
US$99,786 		3,370 +15.6% 29.61 US$99,786
2025-09-30 2025-05-28 S Sale
0.7
Pharmacy Investors, LLC

Member of 10% owner group
150,998 -25.1%
20.16
US$3,044,120 		150,998 -25.1% 20.16 US$3,044,120
2025-09-30 2025-05-28 S Sale
0.7
Cardinal Equity Fund, L.P.

Member of 10% owner group
50,305 -25.1%
20.16
US$1,014,149 		50,305 -25.1% 20.16 US$1,014,149
2025-05-29 2025-05-28 S Sale
0.7
Morris David K

See Remarks

Executive Director
68,547 -24.2%
20.16
US$1,381,908 		68,547 -24.2% 20.16 US$1,381,908
2025-05-29 2025-05-28 S Sale
0.7
Forbes Kendall

See Remarks

Officer
64,991 -24.2%
20.16
US$1,310,219 		64,991 -24.2% 20.16 US$1,310,219
2025-05-29 2025-05-28 S Sale
0.7
BINDLEY WILLIAM E
Non-Executive Director Large shareholder
651,454 -25.1%
20.16
US$13,133,313 		651,454 -25.1% 20.16 US$13,133,313
2025-05-29 2025-05-28 S Sale
0.7
Burke Fred

See Remarks

Executive Director
138,705 -25.1%
20.16
US$2,796,293 		138,705 -25.1% 20.16 US$2,796,293
2025-05-29 2025-05-28 S Sale
0.7
Salentine Thomas J Jr
Non-Executive Director Large shareholder
651,454 -25.1%
20.16
US$13,133,313 		651,454 -25.1% 20.16 US$13,133,313
2025-05-29 2025-05-28 S Sale
0.7
Ackerman John
Non-Executive Director
50,305 -25.1%
20.16
US$1,014,149 		50,305 -25.1% 20.16 US$1,014,149
2025-05-29 2025-05-28 S Sale
0.7
Ackerman John
Non-Executive Director
150,998 -25.1%
20.16
US$3,044,120 		150,998 -25.1% 20.16 US$3,044,120
2025-05-29 2025-05-28 S Sale
0.7
Bindley Capital Partners I, LLC
Large shareholder
651,454 -25.1%
20.16
US$13,133,313 		651,454 -25.1% 20.16 US$13,133,313
2025-09-30 2025-05-27 S Sale
0.7
Pharmacy Investors, LLC

Member of 10% owner group
813,318 -57.5%
20.16
US$16,396,491 		813,318 -57.5% 20.16 US$16,396,491
2025-09-30 2025-05-27 S Sale
0.7
Cardinal Equity Fund, L.P.

Member of 10% owner group
270,958 -57.5%
20.16
US$5,462,513 		270,958 -57.5% 20.16 US$5,462,513
2025-05-29 2025-05-27 S Sale
0.7
Morris David K

See Remarks

Executive Director
369,212 -56.6%
20.16
US$7,443,314 		369,212 -56.6% 20.16 US$7,443,314
2025-05-29 2025-05-27 S Sale
0.7
Forbes Kendall

See Remarks

Officer
350,058 -56.6%
20.16
US$7,057,169 		350,058 -56.6% 20.16 US$7,057,169
2025-05-29 2025-05-27 S Sale
0.7
BINDLEY WILLIAM E
Non-Executive Director Large shareholder
3,508,905 -57.5%
20.16
US$70,739,525 		3,508,905 -57.5% 20.16 US$70,739,525
2025-05-29 2025-05-27 S Sale
0.7
Burke Fred

See Remarks

Executive Director
747,102 -57.5%
20.16
US$15,061,576 		747,102 -57.5% 20.16 US$15,061,576
2025-05-29 2025-05-27 S Sale
0.7
Salentine Thomas J Jr
Non-Executive Director Large shareholder
3,508,905 -57.5%
20.16
US$70,739,525 		3,508,905 -57.5% 20.16 US$70,739,525
2025-05-29 2025-05-27 S Sale
0.7
Ackerman John
Non-Executive Director
270,958 -57.5%
20.16
US$5,462,513 		270,958 -57.5% 20.16 US$5,462,513
2025-05-29 2025-05-27 S Sale
0.7
Ackerman John
Non-Executive Director
813,318 -57.5%
20.16
US$16,396,491 		813,318 -57.5% 20.16 US$16,396,491
2025-05-29 2025-05-27 S Sale
0.7
Bindley Capital Partners I, LLC
Large shareholder
3,508,905 -57.5%
20.16
US$70,739,525 		3,508,905 -57.5% 20.16 US$70,739,525
2024-11-20 2024-11-19 B Purchase
2.8
COSLER STEVEN D
Non-Executive Director
7,000 +65.3%
21.22
US$148,540 		7,000 +65.3% 21.22 US$148,540
2024-10-01 2024-09-27 B Purchase
0.7
Salentine Thomas J Jr
Non-Executive Director
35,714 +inf%
14.00
US$499,996 		35,714 +inf% 14.00 US$499,996
2024-10-01 2024-09-27 B Purchase
2.8
COSLER STEVEN D
Non-Executive Director
7,142 +inf%
14.00
US$99,988 		7,142 +inf% 14.00 US$99,988
2024-10-01 2024-09-27 B Purchase
Patchett Mary Sue
Non-Executive Director
3,571 +inf%
14.00
US$49,994 		3,571 +inf% 14.00 US$49,994
2024-10-01 2024-09-27 B Purchase
3.8
LEWIS RANDALL J
Non-Executive Director
3,571 +inf%
14.00
US$49,994 		3,571 +inf% 14.00 US$49,994
Explore more

More insider trading research around Guardian Pharmacy Services Inc

More insider trades in United States
Similar Consumer Non-Cyclicals companies with insider activity
More Food & Drug Retailing companies with insider activity
More Food & Drug Retailing companies with insider activity
Insider trading in North America